Atlas Trials

Mehmet Akce

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Mehmet Akce

RecordFirmDate
A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma (NCT06855225)Mehmet Akce2026-07-01
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement (NCT06728410)Mehmet Akce2026-01-27

Track Mehmet Akce automatically

Every clearance here is in the API, with alerts when new ones post.